Downloads
Article: Getting The Most From Preclinical Imaging
By Patrick McConville, Ph.D.
The pharmaceutical industry continues to actively adopt imaging technologies to accelerate the drug discovery process. Imaging methods such as magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), computed tomography (CT), and in vivo optical imaging offer important and valuable improvements over traditional drug discovery methods.
These improvements include providing earlier and more highly predictive in vivo data, facilitating clinical translation, and yielding highly quantitative information from the more realistic models of disease that are becoming increasingly available.
Used with permission from Life Science Leader magazine.
The content you requested is only available to registered users of Bioresearch Online. By registering now, you'll get access to this piece of content and thousands of additional articles and product reviews across our entire network of sites.
